Holen Sie sich die Stockscreener-App
2.64
3.00%
0.07
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health Investments Director Loengard Anna U Buys 12000 Shares at $2.6/Share - AInvest
Loengard Anna U buys Clover Health investments (CLOV) shares By Investing.com - Investing.com
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
Clover Health rises after former CEO buys shares - MSN
Clover Health Addresses Shareholder Concerns with FAQ Release - AInvest
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction - The Globe and Mail
Clover Health at Canaccord Conference: Strategic Tech-Driven Growth - Investing.com
Clover Health Investments : August 2025 Investor Presentation - MarketScreener
Clover Health Engages Shareholders with FAQ Release - TipRanks
Clover Health Set To Join Russell 3000® Index - Barchart.com
Insider Buying at Clover Health: A Signal of Value or Short-Term Confidence? - AInvest
Clover Health rises after former CEO buys shares (CLOV) - Seeking Alpha
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover Health Investments Maintains Hold Rating from Leerink Partners, Price Target at $2.50 - AInvest
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Reports Strong Q2 2025 Growth - The Globe and Mail
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View - TradingView
UBS Adjusts Price Target on Clover Health Investments to $3 From $4.50, Maintains Neutral Rating - MarketScreener
Community Health Systems, Inc. shares fall 1.61% premarket after Clover Health reports Q2 loss. - AInvest
Clover Health shares fall 11.58% premarket after reporting a Q2 loss of $10.58 million. - AInvest
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call Highlights: Surpassing Growth ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call High - GuruFocus
Clover Health (CLOV) Q2 Sales Up 34% - AOL.com
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Clover Health Investments Q2 2025 Earnings Call Transcript - AInvest
Clover Health Investments earnings beat by $0.05, revenue topped estimates By Investing.com - Investing.com South Africa
Earnings call transcript: Clover Health Q2 2025 sees revenue beat, stock dips - Investing.com
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details - 富途牛牛
Clover Health (NASDAQ:CLOV) Beats Q2 Sales Targets But Stock Drops - Yahoo Finance
Clover Health Investments Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Clover Health Q2 revenue beats expectations - MarketScreener
Clover Health Q2 2025 slides: 32% membership growth amid sustained profitability - Investing.com Nigeria
Earnings Flash (CLOV) Clover Health Investments, Corp. Reports Q2 Revenue $477.6M, vs. FactSet Est of $468.3M - MarketScreener
3.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):